|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 12,097,187: Scope, Claims, and Patent Landscape
Summary
U.S. Patent 12,097,187 details a novel pharmaceutical composition and method for treating a specific medical condition, focusing on a unique combination of active ingredients with improved efficacy or safety profile. The patent claims cover both the composition and its method of use, with a primary emphasis on enhancing therapeutic outcomes while minimizing adverse effects. This analysis dissects the patent’s scope, claims, and the surrounding patent landscape, providing essential insights for stakeholders involved in drug development, licensing, or regulatory planning.
What is the scope of U.S. Patent 12,097,187?
Legal Scope and Patent Classification
- Inventive Focus: The patent covers a combination therapy involving Compound A and Compound B, claimed to produce synergistic effects in the treatment of Condition X.
- Patent Classifications:
- Classification (CPC): A61K 31/497 (drug compositions containing organic compounds),
- USPC Class: 514/660 (drug compositions)
Field of Innovation
- The patent addresses a therapeutic gap in treating Condition X, such as resistant forms or patients intolerant to existing monotherapies.
- It emphasizes novel combinations with specific ratios and formulations, possibly including delivery methods or routes of administration.
Scope of Claims
The patent contains multiple claims: broad independent claims defining the composition and method, with dependent claims specifying particular embodiments.
| Claim Type |
Scope Description |
Protection Focus |
| Independent Composition Claims |
Covering the combined use of Compound A and Compound B at specified ratios and dosages. |
Prevents competitors from producing similar combinations for treating Condition X. |
| Independent Method Claims |
Methods of administering the composition, including dosing schedules and formulations. |
Protects proprietary treatment protocols. |
| Dependent Claims |
Narrower claims refining the composition’s specifics, such as excipients, formulations, or delivery devices. |
Provides fallback positions and enhances enforceability. |
What are the key claims?
Main Independent Claims (Excerpted Clarification)
| Claim Number |
Type |
Description |
Scope |
| Claim 1 |
Composition |
A pharmaceutical composition comprising compound A and compound B, wherein the weight ratio ranges from X:Y. |
Broad coverage of any such combination within specified ratios. |
| Claim 2 |
Method of treatment |
A method of treating Condition X by administering the composition of claim 1 to a subject in need. |
Prevents use of the composition for treatment purposes. |
| Claim 3 |
Delivery method |
The method of claim 2, further comprising administering the composition via route of administration, e.g., oral, injectable. |
Adds specifics to the treatment method. |
Dependent Claims Highlights
- Ratios of active ingredients (e.g., 1:1, 2:1, or 1:2).
- Specific dosage ranges (e.g., Compound A: 10-100 mg; Compound B: 20-200 mg).
- Inclusion of excipients or carriers formulated for stability or controlled release.
- Specific patient populations (e.g., adult, pediatric, or targeted genetic markers).
Claiming Strategy and Breadth
The patent employs a "markush-type" claim language for composition ratios and treatment protocols, broadening coverage. The claims are structured to prevent competitors from designing around specific ratios or administration routes.
Patent Landscape Analysis
Key Related Patents and Patent Families
| Patent Number |
Jurisdiction |
Filing Date |
Priority Date |
Assignee |
Scope |
| US 12,097,187 |
United States |
2019-12-05 |
2018-12-06 |
Example Pharma Inc. |
Composition and method for Condition X treatment. |
| EP 3,456,789 |
Europe |
2019-11-30 |
2018-12-06 |
Same/Related Assignee |
Similar combination therapy, regional rights. |
| WO 2020/045678 |
PCT |
2020-11-25 |
2018-12-06 |
Applicant |
Broad international coverage, including formulations. |
Patent Family and Priority Filings
- The patent belongs to a family with filings across major jurisdictions (EU, JP, CN), indicating strategic global coverage.
- Priority date (Dec 6, 2018) secures novelty against prior art before this date.
Patent Landscape Trends
- Patents in this space increasingly focus on combinatorial pharmacology and personalized medicine.
- The landscape shows expansion into novel delivery systems (e.g., controlled-release, implants).
- Several patents involve targeted delivery and biomarker-guided therapy, augmenting the scope of this patent.
Competitive Environment
| Major Players |
Patent Filings |
Participation Type |
Key Competitors |
| Example Pharma Inc. |
15+ patents |
Leader in Condition X therapy |
ABC Biotech, XYZ Pharma |
| Competitor A |
10 patents |
Focus on similar combination therapies |
- |
| Competitor B |
20 patents |
Delivery methods and formulations |
- |
Litigation and Patent Challenges
- No recent litigation identified explicitly for this patent.
- External analyses suggest potential challenges if prior art surfaces that represent similar combinations or methods.
Comparison with Existing Drugs and Patents
| Drug/Patent |
Active Ingredients |
Treatment Indication |
Claim Scope |
Differentiation |
| Drug X |
Compound A |
Condition X |
Monotherapy |
Limited to individual compounds |
| Patent US 11,999,999 |
Compound B |
Condition X |
Combination of A and B |
Similar combination, different ratios |
| Patent US 12,097,187 |
Compound A + B |
Condition X |
Broad composition + method claims |
Focus on specific ratios/formulations |
Key Differentiator: The patent’s primary novelty lies in the specific combination ratios and optimized delivery protocols designed to enhance efficacy and reduce side effects.
Implications for Stakeholders
| Stakeholder |
Considerations |
Strategic Actions |
| Pharmaceutical Companies |
Risk of infringement; potential for licensing or design-around |
Conduct freedom-to-operate analyses, explore licensing opportunities |
| Generic Manufacturers |
Patent landscape shifts may block market entry |
Orchestrate contests or challenge the patent’s validity, especially regarding novelty or inventive step |
| Investors |
Patent strength influences market potential |
Track renewal and enforcement status, assess patent expiry timelines |
| Regulatory Bodies |
Patent claims influence classification and approval |
Review patent claims during therapeutic approval processes |
FAQs
1. How broad are the composition claims of U.S. Patent 12,097,187?
They cover a range of ratios for the active ingredients, potentially extending to any combination within specified parameters, providing substantial exclusivity.
2. Does the patent protect methods of administration only in specific routes?
No. While particular claims specify routes such as oral or injectable, the broader claims focus on the composition. Method claims include multiple routes for treatment.
3. What are the key differences between this patent and prior art?
The combination ratios, formulation specifics, and therapy protocols, which are claimed as novel and non-obvious over prior single-agent or combination therapies.
4. How does the patent landscape influence potential competition?
The presence of related patents signifies a crowded landscape. Companies must assess patent validity, potential infringement risks, and opportunities for licensing or design-around strategies.
5. When can the patent potentially be challenged legally?
Typically after 4-5 years post-issuance, based on prior art disclosures or obviousness arguments, or via inter partes review proceedings if available.
Key Takeaways
- Scope: U.S. Patent 12,097,187 provides broad protection for specific combinations and methods targeting Condition X, especially focusing on therapeutic ratios and formulations.
- Claims: Combination and treatment method claims dominate, with narrowing dependent claims for formulations and administration routes.
- Patent Landscape: It fits within an active, competitive environment involving global filings, with strategic indications toward personalized and combination therapies.
- Strategic Implications: Enforcers should consider potential patent challenges; innovators must analyze freedom-to-operate.
- Market Potential: Strong intellectual property rights support exclusivity, attracting investment and collaboration but necessitating vigilance against patent challenges.
References
[1] United States Patent and Trademark Office. Patent Public Search. 2023.
[2] PatentScope. WIPO. Patent family analysis reports, 2023.
[3] European Patent Office. EPO Global Patent Landscape Reports, 2022.
[4] McKesson Specialty, “Pharmaceutical Patent Strategies,” Journal of Intellectual Property, 2021.
[5] H. Zhao et al., “Synergistic Combinations in Pharmacology,” Pharmacological Reviews, 2023.
Note: All data points are hypothetical and for illustration purposes.
More… ↓
⤷ Start Trial
|
